Pancreatic hyperenzymemia: Clinical significance and diagnostic approach

Journal of the Pancreas

Volumn 6, Issue 6, 2005, Pages 536-551

  Frulloni, Luca ^a,b   Patrizi, Franca ^a   Bernardoni, Laura ^a   Cavallini, Giorgio ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Policlinico GB Rossi   (Italy)

Author keywords

Amylases metabolism; Cholangiopancreatography, endoscopic retrograde; Diagnosis; Hyperamylasemia etiology; Lipase metabolism; Magnetic resonance imaging

Indexed keywords

AMYLASE; AZATHIOPRINE; CLOZAPINE; CYCLOSPORIN; DIDANOSINE; ENZYME PRECURSOR; EPHEDRINE; PANCREAS ENZYME; PARACETAMOL; PENTAMIDINE; RITODRINE; ROXITHROMYCIN; SECRETIN; STEROID; TRIACYLGLYCEROL LIPASE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACIDEMIA; ACINAR CELL; AMYLASE BLOOD LEVEL; BILE DUCT OBSTRUCTION; COMPUTER ASSISTED TOMOGRAPHY; DIABETIC KETOACIDOSIS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; ECHOGRAPHY; EDITORIAL; ENZYME BLOOD LEVEL; HUMAN; HYPERAMYLASEMIA; KIDNEY DISEASE; LIVER DISEASE; LIVER SCINTISCANNING; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; ODDI SPHINCTER; PANCREAS CANCER; PANCREAS DISEASE; PATHOGENESIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

AMYLASES; CHOLANGIOGRAPHY; HUMANS; LIPASE; PANCREATIC DISEASES; PANCREATIC NEOPLASMS;

EID: 27944448515     PISSN: 15908577     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Editorial

References (228)

1. Vissers RJ, Abu-Laban RB, McHugh DF. Amylase and lipase in the emergency department evaluation of acute pancreatitis. J Emerg Med 1999; 17:1027-37.
2. Lang E, Afilalo M, Dankoff J, Colacone A, Tselios C, Guttman A. The prognostic significance of moderate hyperamylasemia in the evaluation of the emergency department patient. J Emerg Med 1995; 13:107-12.
3. Wasle B, Edwardson JM. The regulation of exocytosis in the pancreatic acinar cell. Cell Signal 2002; 14:191-7.
4. Pandol SJ. Neurohumoral control of exocrine pancreatic secretion. Curr Opin Gastroenterol 2004; 20:435-8.
5. Chey WY, Chang T. Neural hormonal regulation of exocrine pancreatic secretion. Pancreatology 2001; 1:320-35.
6. Mooren FCh, Hlouschek V, Finkes T, Turi S, Weber IA, Singh J, et al. Early changes in pancreatic acinar cell calcium signaling after pancreatic duct obstruction. J Biol Chem 2003; 278:9361-9.
7. Terada T, Kida T, Nakanuma Y. Extrahepatic peribiliary glands express alpha-amylase isozymes, trypsin and pancreatic lipase: an immunohistochemical analysis. Hepatology 1993; 18:803-8.
8. Hamosh M, Scow RO. Lingual lipase and its role in the digestion of dietary lipid. J Clin Invest 1973; 52:88-95.
9. Hamosh M. Lingual and gastric lipases. Nutrition 1990; 6:421-8.
10. DeNigris SJ, Hamosh M, Kasbekar DK, Lee TC, Hamosh P. Lingual and gastric lipases: species differences in the origin of prepancreatic digestive lipases and in the localization of gastric lipase. Biochim Biophys Acta 1988; 959:38-45.
11. Zambon A, Bertocco S, Vitturi N, Polentarutti V, Vianello D, Crepaldi G. Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins. Biochem Soc Trans 2003; 31:1070-4.
12. Tietz NW, Shuey DF. Lipase in serum - the elusive enzyme: an overview. Clin Chem 1993; 39:746-56.
13. Lott JA, Lu CJ. Lipase isoforms and amylase isoenzymes: assays and application in the diagnosis of acute pancreatitis. Clin Chem 1991; 37:361-8.
14. Panteghini M. Electrophoretic fractionation of pancreatic lipase: Clin Chem 1992; 38:1712-6.
15. Duane WC, Frerichs R, Levitt MD. Distribution, turnover, and mechanism of renal excretion of amylase in the baboon. J Clin Invest 1971; 50:156-65.
16. Moller-Peterson J, Dati F. Renal handling of pancreatic lipase. Clin Chem 1984; 30:343-4.
17. Junge W, Malyusz M, Ehrens HJ. The role of the kidney in the elimination of pancreatic lipase and amylase from blood. J Clin Chem Clin Biochem 1985; 23:387-92.
18. Donaldson LA, Joffe SN, McIntosh W, Brodie MJ. Amylase activity in human bile. Gut 1979; 20:216-8.
19. Rosenblum JL, Raab BK, Alpers DH. Hepatobiliary and pancreatic clearance of circulating pancreatic amylase. Am J Physiol 1982; 243:G21-7.
20. Buchman AL, Ament ME, Moukarzel A. Total serum amylase but not lipase correlates with measured glomerular filtration rate. J Clin Gastroenterol 1993; 16:204-6.
21. Pezzilli R, Andreone P, Morselli-Labate AM, Sama C, Billi P, Cursaro C et al. Serum pancreatic enzyme concentrations in chronic viral liver diseases. Dig Dis Sci 1999; 44:350-5.
22. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994; 330:1198-210.
23. Scheele G, Adler G, Kern H. Exocytosis occurs at the lateral plasma membrane of the pancreatic acinar cell during supramaximal secretagogue stimulation. Gastroenterology 1987; 92:345-53.
24. Saluja A, Saluja M, Villa A, Leli U, Rutledge P, Meldolesi J, Steer M. Pancreatic duct obstruction in rabbits causes digestive zymogen and lysosomal enzyme colocalization. J Clin Invest 1989; 84:1260-6.
25. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy - Italian Group. N Engl J Med 1996; 335:919-23.
26. Kamisawa T, Matsukawa M, Amemiya K, Tu Y, Egawa N, Okamoto A, Aizawa S. Pancreatitis associated with pancreaticobiliary maljunction. Hepatogastroenterology 2003; 50:1665-8.
27. Vinicor F, Lehrner LM, Karn RC, Merritt AD. Hyperamylasemia in diabetic ketoacidosis: sources and significance. Ann Intern Med 1979; 91:200-4.
28. Frank B, Gottlieb K. Amylase normal, lipase elevated: is it pancreatitis? A case series and review of the literature. Am J Gastroenterol 1999; 94:463-9.
29. Haddad NG, Croffie JM, Eugster EA. Pancreatic enzyme elevations in children with diabetic ketoacidosis. J Pediatr 2004; 145:122-4.
30. Tsukawaki M, Izawa M, Yoshida M, Araki N, Hashiba Y, Nakagawa H, et al. A case of amylase-producing lung cancer. Intern Med 1992; 31:60-3.
31. Yagi C, Miyata J, Hanai J, Ogawa M, Ueda G. Hyperamylasemia associated with endometrioid carcinoma of the ovary: case report and immunohistochemical study. Gynecol Oncol 1986; 25:250-5.
32. Benedetti G, Rastelli F, Damiani S, Calandri C, Crino L. Challenging problems in malignancy: case 1. Presentation of small-cell lung cancer with marked hyperamylasemia. J Clin Oncol 2004; 22:3826-8.
33. Hayakawa T, Kameya A, Mizuno R, Noda A, Kondo T, Hirabayashi N. Hyperamylasemia with papillary serous cystadenocarcinoma of the ovary. Cancer 1984; 54:1662-5.
34. Roberts I, Chopra S, Warshaw AL. Carcinoma of the lung with marked hyperamylasemia and elevated serum calcitonin. Am J Gastroenterol 1982; 77:43-4.
35. Martin PC, Sarma DP. Amylase-producing lung cancer. J Surg Oncol 1982; 21:30-2.
36. Norwood SH, Torma MJ, Fontenelle LJ. Hyperamylasemia due to poorly differentiated adenosquamous carcinoma of the ovary. Arch Surg 1981; 116:225-6.
37. Sandiford JA, Chiknas SG. Hyperamylasemia and ovarian carcinoma. Clin Chem 1979; 25:948-50.
38. Flood JG, Schuerch C, Dorazio RC, Bowers GN Jr. Marked hyperamylasemia associated with carcinoma of the lung. Clin Chem 1978; 24:1207-12.
39. Berk JE, Shimamura J, Fridhandler L. Tumor-associated hyperamylasemia. Am J Gastroenterol 1977; 68:572-7.
40. Ammann RW, Berk JE, Fridhandler L, Ueda M, Wegmann W. Hyperamylasemia with carcinoma of the lung. Ann Intern Med 1973; 78:521-6.
41. Salt WB 2nd, Schenker S. Amylase - its clinical significance: a review of the literature. Medicine (Baltimore) 1976; 55:269-89.
42. Otsuki M, Yuu H, Maeda M, Saeki S, Yamasaki T. Amylase in the lung. Cancer 1977; 39:1656-63.
43. Chow AW, Soll BA, Targan SR, Buze LB. Hyperamylasemia associated with gonococcal salpingitis and perihepatitis. Obstet Gynecol 1976; 48:29S-30S.
44. Cavallini G, Frulloni L, Vaona B, Di Francesco V, Bovo P. Is hyperamylasemia related to dyslipidemia? Gastroenterology 1997; 112:1058-9.
45. Yoffe B, Bagri AS, Tran T, Dural AT, Shtenberg KM, Khaoustov VI. Hyperlipasemia associated with hepatitis C virus. Dig Dis Sci 2003; 48:1648-53.
46. Mishra A, Saigal S, Gupta R, Sarin SK. Acute pancreatitis associated with viral hepatitis: a report of six cases with review of literature. Am J Gastroenterol 1999; 94:2292-5.
47. Pal AK, Krishnan S, Bose M. Serum amylase in viral hepatitis. J Assoc Physicians India 1983; 31:83-6.
48. Tewari SG, Tyagi SP, Vaid AK, Sibghatullah. Serum amylase and its isoenzymes in cases of viral hepatitis. Gastroenterol Jpn 1981; 16:441-6.
49. Singhal M, Sharma P, Bhardwaja B, Swaroop A, Mathur JS. Study of serum amylase in acute viral hepatitis. J Assoc Physicians India 1993; 41:136-7.
50. Taranto D, Carrato A, Romano M, Maio G, Izzo CM, Del Vecchio Blanco C. Mild pancreatic damage in acute viral hepatitis. Digestion 1989; 42:93-7.
51. Rizzotti P, Zanini D, Montesi G, Lechi A, Burlina A. Exocrine pancreatic involvement in acute viral hepatitis. Ric Clin Lab 1984; 14:431-3.
52. Shimoda T, Shikata T, Karasawa T, Tsukagoshi S, Yoshimura M, Sakurai I. Light microscopic localization of hepatitis B virus antigens in the human pancreas. Possibility of multiplication of hepatitis B virus in the human pancreas. Gastroenterology 1981; 81:998-1005.
53. Yoshimura M, Sakurai I, Shimoda T, Abe K, Okano T, Shikata T. Detection of HBsAg in the pancreas. Acta Pathol Jpn 1981; 31:711-7.
54. Yan FM, Chen AS, Hao F, Zhao XP, Gu CH, Zhao LB, et al. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol 2000; 6:805-811.
55. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology 1998; 28:1398-401.
56. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333:1657-61.
57. Araki T, Ueda M, Taketa K, Kosaka K. Pancreatic-type hyperamylasemia in end-stage renal disease. Dig Dis Sci 1989; 34:1425-7.
58. Collen MJ, Ansher AF, Chapman AB, Mackow RC, Lewis JH. Serum amylase in patients with renal insufficiency and renal failure. Am J Gastroenterol 1990; 85:1377-80.
59. Vaziri ND, Chang D, Malekpour A, Radaht S. Pancreatic enzymes in patients with end-stage renal disease maintained on hemodialysis. Am J Gastroenterol 1988; 83:410-2.
60. Masoero G, Bruno M, Gallo L, Colaferro S, Cosseddu D, Vacha GM. Increased serum pancreatic enzymes in uremia: relation with treatment modality and pancreatic involvement. Pancreas 1996; 13:350-5.
61. Barera G, Bazzigaluppi E, Viscardi M, Renzetti F, Bianchi C, Chiumello G, Bosi E. Macroamylasemia attributable to gluten-related amylase autoantibodies: a case report. Pediatrics 2001; 107:E93.
62. Bonetti G, Serricchio G, Giudici A, Bettonagli M, Vadacca GB, Bruno R, et al. Hyperamylasemia due to macroamylasemia in adult gluten enteropathy. Scand J Clin Lab Invest 1997; 57:271-3.
63. Kazmierczak SC, Van Lente F, McHugh AM, Katzin WE. Macroamylasemia with a markedly increased amylase clearance ratio in a patient with renal cell carcinoma. Clin Chem 1988; 34:435-8.
64. Sagristani M, Guariglia R, Pocali B, De Rienzo M, Guastafierro S, Romano G, Tirelli A. Macroamylasemia in a patient with multiple myeloma. Leuk Lymphoma 2002; 43:1705-7.
65. Rosenblum JL, Hortin GL, Smith CH, Pashos GE, Landt M. Macroamylases: differences in activity against various-sized substrates. Clin Chem 1992; 38:1725-9.
66. Zimmerman HM, Bank S, Buch P, Katzka I, Lendvai S. Macroamylase in the pleural fluid of a patient with lymphoma: Gastroenterology 1983; 85:190-3.
67. Fujimura Y, Nishishita C, Uchida J, Iida M. Macroamylasemia associated with ulcerative colitis. J Mol Med 1995; 73:95-7.
68. Faro RS, Trafton HF, Organ CH Jr. Macroamylasemia. Surgery 1977; 82:552-4.
69. Gottlieb K, Sherman S, Pezzi J, Esber E, Lehman GA. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes. Am J Gastroenterol 1996; 91:1553-7.
70. Paajanen H, Nuutinen P, Harmoinen A, Poyhonen M, Pitkanen O, Nordback I, et al. Hyperamylasemia after cardiopulmonary bypass: pancreatic cellular injury or impaired renal excretion of amylase? Surgery 1998; 123:504-10.
71. Hashimoto N, Haji S, Nomura H, Ohyanagi H. Hyperamylasemia after hepatic resection. Hepatogastroenterology 2003; 50:1472-3.
72. Kubota K, Makuuchi M, Noie T, Kusaka K, Sakamoto Y, Miki K, et al. Risk factors for hyperamylasemia after hepatectomy using the Pringle maneuver: randomized analysis of surgical parameters. Arch Surg 1998; 133:303-8.
73. Galasso PJ, Litin SC, O'Brien JF. The macroenzymes: a clinical review. Mayo Clin Proc 1993; 68:349-54.
74. Remaley AT, Wilding P. Macroenzymes: biochemical characterization, clinical significance, and laboratory detection. Clin Chem 1989; 35:2261-70.
75. Kiechle FL, Quattrociocchi-Longe TM, Brinton DA, Gordon SC, Sykes E, Elkhalifa MY. Autoantibodies to specific enzymes: a review. Ann Clin Lab Sci 1996; 26:195-207.
76. Stasia MJ, Surla A, Renversez JC, Pene F, Morel-Femelez A, Morel F. Aspartate aminotransferase macroenzyme complex in serum identified and characterized. Clin Chem 1994; 40:1340-3.
77. Tharakan J, Hossenbocus A, Arthur MJ. Macromolecular aspartate aminotransferase. Eur J Gastroenterol Hepatol 1998; 10:1055-6.
78. Perry C, Peretz H, Ben-Tal O, Eldor A. Highly elevated lactate dehydrogenase level in a healthy individual: a case of macro-LDH. Am J Hematol 1997; 55:39-40.
79. Berk JE. Mechanisms of macroamylasemia. N Engl J Med 1968; 278:509.
80. Stein AM. Macroamylasemia. Postgrad Med 1974; 55:103-5.
81. Adachi K, Suzuki K, Ohno Y, Sato B. Impaired amylase activities caused by binding of abnormal immunoglobulin A in patients with macroamylasemia. Clin Chim Acta 1986; 154:103-13.
82. Bode C, Riederer J, Brauner B, Bode JC. Macrolipasemia: a rare cause of persistently elevated serum lipase. Am J Gastroenterol 1990; 85:412-6.
83. Keating JP, Lowe ME. Persistent hyperlipasemia caused by macrolipase in an adolescent. J Pediatr 2002; 141:129-31.
84. Taes YE, Louagie H, Yvergneaux JP, De Buyzere ML, De Puydt H, Delanghe JR, Lott JA. Prolonged hyperlipasemia attributable to a novel type of macrolipase. Clin Chem 2000; 46:2008-13.
85. Gullo L. Familial pancreatic hyperenzymemia. Pancreas 2000; 20:158-60.
86. Czako L, Yamamoto M, Otsuki M. Exocrine pancreatic function in rats after acute pancreatitis. Pancreas 1997; 15:83-90.
87. Andersson E, Andersson R. Exocrine insufficiency in acute pancreatitis. Scand J Gastroenterol 2004; 39:1035-9.
88. Mortele KJ, Wiesner W, Zou KH, Ros PR, Silverman SG. Asymptomatic nonspecific serum hyperamylasemia and hyperlipasemia: spectrum of MRCP findings and clinical implications. Abdom Imaging 2004; 29:109-14.
89. Kurzweil SM, Shapiro MJ, Andrus CH, Wittgen CM, Herrmann VM, Kaminski DL. Hyperbilirubinemia without common bile duct abnormalities and hyperamylasemia without pancreatitis in patients with gallbladder disease. Arch Surg 1994; 129:829-33.
90. Warshaw AL, Lesser PB. Amylase clearance in differentiating acute pancreatitis from peptic ulcer with hyperamylasemia. Ann Surg 1975; 181:314-6.
91. Imrie CW, Whyte AS, Frew EM. A pattern of serum amylase concentration in the initial 24 hours after perforation of duodenal ulcers. J R Coll Surg Edinb 1974; 19:370-3.
92. Krippaehne WW, Fletcher WS, Dunphy JE. Acute perforation of duodenal and gastric ulcer. Factors influencing mortality. Arch Surg 1964; 88:874-82.
93. Rogers FA. Elevated serum amylase: a review and an analysis of findings in 1,000 cases of perforated peptic ulcer. Ann Surg 1961; 153:228-40.
94. Hagan JC, Schoen AM, McGeachin RL. Serum amylase in peptic ulcer. Am J Dig Dis 1952; 19:72-3.
95. Wapshaw H. Significance of raised serum-enzyme levels in perforated peptic ulcer. Br Med J 1951; 4713:995-7.
96. Orlando R 3rd, Gleason E, Drezner AD. Acute acalculous cholecystitis in the critically ill patient. Am J Surg 1983; 145:472-6.
97. Owen CC, Jain R. Acute acalculous cholecystitis. Curr Treat Options Gastroenterol 2005; 8:99-104.
98. Linos DA, Van Heerden JA. Abdominal pain, gallstones, and hyperamylasemia - a clinical dilemma. Minn Med 1981; 64:401-3, 396.
99. Pace BW, Bank S, Wise L, Burson LC, Borrero E. Amylase isoenzymes in the acute abdomen: an adjunct in those patients with elevated total amylase. Am J Gastroenterol 1985; 80:898-901.
100. Swensson EE, King ME, Malekpour A, Maull KI. Serum amylase isoenzyme alterations in acute abdominal conditions. Ann Emerg Med 1985; 14:421-3.
101. Foucault P, Drosdowsky MA. Differential diagnosis of an hyperamylasemia in an acute abdominal syndrome. Clin Chim Acta 1990; 193:91-2.
102. Byrne JJ, Boyd TF. Hyperamylasemia in intestinal obstruction and its relationship to pancreatitis. Am J Surg 1963; 105:720-9.
103. Merine D, Fishman EK, Jones B, Siegelman SS. Enteroenteric intussusception: CT findings in nine patients. AJR Am J Roentgenol 1987; 148:1129-32.
104. Mithofer K, Warshaw AL. Recurrent acute pancreatitis caused by afferent loop stricture after gastrectomy. Arch Surg 1996; 131:561-5.
105. Castilho Netto JM, Speranzini MB. Ampullary duodenal diverticulum and cholangitis. Sao Paulo Med J 2003; 121:173-5.
106. Black PR, Welch KJ, Eraklis AJ. Juxtapancreatic intestinal duplications with pancreatic ductal communication: a cause of pancreatitis and recurrent abdominal pain in childhood. J Pediatr Surg 1986; 21:257-61.
107. Cremonte LG, Mantellini E. An association of acute pancreatitis and intestinal infarct due to superior mesenteric artery occlusion. Minerva Med 1989; 80:505-6.
108. Castiglione F, Del Vecchio Blanco G, Rispo A, Mazzacca G. Prevention of pancreatitis by weekly amylase assay in patients with Crohn's disease treated with azathioprine. Am J Gastroenterol 2000; 95:2394-5.
109. Katz S, Bank S, Greenberg RE, Lendvai S, Lesser M, Napolitano B. Hyperamylasemia in inflammatory bowel disease. J Clin Gastroenterol 1988; 10:627-30.
110. Tromm A, Holtmann B, Huppe D, Kuntz HD, Schwegler U, May B. Hyperamylasemia, hyperlipasemia and acute pancreatitis in chronic inflammatory bowel diseases. Leber Magen Darm 1991; 21:15-6, 19-22.
111. Okumura Y, Tamba J, Shintani Y, Yoshioka U, Inoue H, Fujiyama Y, Bamba T. Macrolipasemia in Crohn's disease. Pancreas 1998; 16:205-10.
112. Heikius B, Niemela S, Lehtola J, Karttunen TJ. Elevated pancreatic enzymes in inflammatory bowel disease are associated with extensive disease. Am J Gastroenterol 1999; 94:1062-9.
113. Bokemeyer B. Asymptomatic elevation of serum lipase and amylase in conjunction with Crohn's disease and ulcerative colitis. Z Gastroenterol 2002; 40:5-10.
114. Tositti G, Fabris P, Barnes E, Furlan F, Franzetti M, Stecca C, et al. Pancreatic hyperamylasemia during acute gastroenteritis: incidence and clinical relevance. BMC Infect Dis 2001; 1:18.
115. Ben-Horin S, Farfel Z, Mouallem M. Gastroenteritis-associated hyperamylasemia: prevalence and clinical significance. Arch Intern Med 2002; 162:689-92.
116. Shapiro R, Dropkin R, Finkelstein J, Aledort D, Greenstein AJ. Ovarian carcinomatosis presenting with hyperamylasemia and pleural effusion. Am J Gastroenterol 1981; 76:365-8.
117. Matsuta M, Murakami K, Ono H, Saitoh S, Nishiya I, Takayama K. Hyperamylasemia in endometrial adenocarcinoma. Nippon Sanka Fujinka Gakkai Zasshi 1989; 41:1557-64.
118. Schlikker I, Nakad A, Gerbaux A, Azzouzi K, Kadou J, Lezaire P, et al. Hyperamylasemia with papillary serous cystadenocarcinoma of the ovary. Acta Clin Belg 1989; 44:255-8.
119. O'Riordan T, Gaffney E, Tormey V, Daly P. Hyperamylasemia associated with progression of a serous surface papillary carcinoma. Gynecol Oncol 1990; 36:432-4.
120. Juang CM, Yeng MS, Twu NF, Chao GC. Hyperamylasemia associated with endometroid carcinoma of the ovary. Zhonghua Yi Xue Za Zhi (Taipei) 2000; 63:710-3.
121. Jacobs E, Jennette JC, Reavis RA. Chronic hyperamylasemia and chronic pelvic inflammatory disease. Clin Chem 1983; 29:887-8.
122. Tunuguntla A, Van Buren N, Mathews MR, Ehrenfried JA. Endometriosis of the pancreas presenting as a cystic pancreatic neoplasm with possible metastasis. South Med J 2004; 97:1020-1.
123. Marchevsky AM, Zimmerman MJ, Aufses AH Jr., Weiss H. Endometrial cyst of the pancreas. Gastroenterology 1984; 86:1589-91.
124. Verbeke C, Harle M, Sturm J. Cystic endometriosis of the upper abdominal organs. Report on three cases and review of the literature. Pathol Res Pract 1996; 192:300-4.
125. Bateman BG, McKinney CD, Bruns DE. Serum amylase isoenzymes in ectopic pregnancy. Fertil Steril 1993; 59:461-2.
126. Christensen H, Larsen MO, Schebye O. Serum amylase levels in gynecologic patients with acute abdominal pain. Surg Gynecol Obstet 1992; 175:355-6.
127. Roberge RJ, Wears RL, Sanz C, Nicholson TR, Brennan DF. Serum amylase levels in ectopic pregnancy. Am J Emerg Med 1988; 6:327-9.
128. Kelley ML Jr. Elevated serum amylase level associated with ruptured ectopic pregnancy. J Am Med Assoc 1957; 164:406-7.
129. Rackoff A, Shores N, Willner I. Mesenteric venous thrombosis in a patient with pancreatitis and protein C deficiency. South Med J 2005; 98:232-4.
130. Mamode N, Pickford I, Leiberman P. Failure to improve outcome in acute mesenteric ischaemia: seven-year review. Eur J Surg 1999; 165:203-8.
131. Pombo F, Marini M, Beraza A, Rodriguez E. Aortic dissection presenting as acute pancreatitis: CT diagnosis. Comput Med Imaging Graph 1991; 15:407-9.
132. Adam DJ, Milne AA, Evans SM, Roulston JE, Lee AJ, Ruckley CV, Bradbury AW. Serum amylase isoenzymes in patients undergoing operation for ruptured and non-ruptured abdominal aortic aneurysm. J Vasc Surg 1999; 30:229-35.
133. Boddie DE, Couper GW, Watson H, Cooper GG. Isoenzyme analysis of hyperamylasaemia associated with ruptured abdominal aortic aneurysms. J R Coll Surg Edinb 1998; 43:306-7.
134. Bagley JS, Tyler MP, Cooper GG. Hyperamylasaemia in ruptured aortic aneurysm: incidence and prognostic implications. Br J Surg 1994; 81:31-2.
135. Boulanger BR, Milzman DP, Rosati C, Rodriguez A. The clinical significance of acute hyperamylasemia after blunt trauma. Can J Surg 1993; 36:63-9.
136. Keller MS, Coln CE, Trimble JA, Green MC, Weber TR. The utility of routine trauma laboratories in pediatric trauma resuscitations. Am J Surg 2004; 188:671-8.
137. Dodds WJ, Taylor AJ, Erickson SJ, Lawson TL. Traumatic fracture of the pancreas: CT characteristics. J Comput Assist Tomogr 1990; 14:375-8.
138. Jobst MA, Canty TG Sr., Lynch FP. Management of pancreatic injury in pediatric blunt abdominal trauma. J Pediatr Surg 1999; 34:818-23.
139. Lambertus MW, Anderson RE. Hyperamylasemia in patients with human immunodeficiency virus infection. N Engl J Med 1990; 323:1708-9.
140. Murthy UK, DeGregorio F, Oates RP, Blair DC. Hyperamylasemia in patients with the acquired immunodeficiency syndrome. Am J Gastroenterol 1992; 87:332-6.
141. Zuger A. Hyperamylasemia and facial swelling in an HIV-infected man. AIDS Clin Care 1995; 7:7-9.
142. Argiris A, Mathur-Wagh U, Wilets I, Mildvan D. Abnormalities of serum amylase and lipase in HIV-positive patients. Am J Gastroenterol 1999; 94:1248-52.
143. Takahashi M, Maemura K, Sawada Y, Yoshioka T, Sugimoto T. Hyperamylasemia in critically injured patients. J Trauma 1980; 20:951-5.
144. Farkouh E, Wassef R, Atlas H, Allard M. Importance of the serum amylase level in patients with blunt abdominal trauma. Can J Surg 1982; 25:626-8.
145. Bouwman DL, Altshuler J, Weaver DW. Hyperamylasemia: a result of intracranial bleeding. Surgery 1983; 94:318-23.
146. Vitale GC, Larson GM, Davidson PR, Bouwman DL, Weaver DW. Analysis of hyperamylasemia in patients with severe head injury. J Surg Res 1987; 43:226-33.
147. Ryan S, Sandler A, Trenhaile S, Ephgrave K, Garner S. Pancreatic enzyme elevations after blunt trauma. Surgery 1994; 116:622-7.
148. Pezzilli R, Billi P, Barakat B, Fiocchi M, Re G, Gullo L, Miglio F. Serum pancreatic enzymes in patients with coma due to head injury or acute stroke. Int J Clin Lab Res 1997; 27:244-6.
149. Eckfeldt JH, Leatherman JW, Levitt MD. High prevalence of hyperamylasemia in patients with acidemia. Ann Intern Med 1986; 104:362-3.
150. Warshaw AL, O'Hara PJ. Susceptibility of the pancreas to ischemic injury in shock. Ann Surg 1978; 188:197-201.
151. Moller-Petersen J, Andersen PT, Hjorne N, Ditzel J. Hyperamylasemia, specific pancreatic enzymes, and hypoxanthine during recovery from diabetic ketoacidosis. Clin Chem 1985; 31:2001-4.
152. Nsien EE, Steinberg WM, Borum M, Ratner R. Marked hyperlipasemia in diabetic ketoacidosis. A report of three cases. J Clin Gastroenterol 1992; 15:117-21.
153. Yadav D, Nair S, Norkus EP, Pitchumoni CS. Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol 2000; 95:3123-8.
154. Belfiore F, Napoli E. Interpretation of hyperamylasemia in diabetic coma. Clin Chem 1973; 19:387-9.
155. van Sonnenberg E, Pitchumoni CS. Prolonged hyperamylasemia in diabetic ketoacidosis. Jama 1976; 236:482-3.
156. Weaver DW, Busuito MJ, Bouwman DL, Wilson RF. Interpretation of serum amylase levels in the critically ill patient. Crit Care Med 1985; 13:532-3.
157. Kameya S, Hayakawa T, Kameya A, Watanabe T. Hyperamylasemia in patients at an intensive care unit. J Clin Gastroenterol 1986; 8:438-42.
158. Justice AD, DiBenedetto RJ, Stanford E. Significance of elevated pancreatic enzymes in intracranial bleeding. South Med J 1994; 87:889-93.
159. Humphries LL, Adams LJ, Eckfeldt JH, Levitt MD, McClain CJ. Hyperamylasemia in patients with eating disorders. Ann Intern Med 1987; 106:50-2.
160. Hempen I, Lehnert P, Fichter M, Teufel J. Hyperamylasemia in anorexia nervosa and bulimia nervosa. Indication of a pancreatic disease? Dtsch Med Wochenschr 1989; 114:1913-6.
161. Jacoby GE. Hyperamylasemia in anorexia and bulimia. Dtsch Med Wochenschr 1990; 115:718.
162. Walsh BT, Wong LM, Pesce MA, Hadigan CM, Bodourian SH. Hyperamylasemia in bulimia nervosa. J Clin Psychiatry 1990; 51:373-7.
163. Kinzl J, Biebl W, Herold M. Hyperamylasemia and salivary gland enlargements in patients with eating disorders. J Clin Psychiatry 1991; 52:139-40.
164. Scheutzel P, Gerlach U. Alpha-amylase isoenzymes in serum and saliva of patients with anorexia and bulimia nervosa. Z Gastroenterol 1991; 29:339-45.
165. Kinzl J, Biebl W, Herold M. Significance of vomiting for hyperamylasemia and sialadenosis in patients with eating disorders. Int J Eat Disord 1993; 13:117-24.
166. Metzger ED, Levine JM, McArdle CR, Wolfe BE, Jimerson DC. Salivary gland enlargement and elevated serum amylase in bulimia nervosa. Biol Psychiatry 1999; 45:1520-2.
167. Robertson C, Millar H. Hyperamylasemia in bulimia nervosa and hyperemesis gravidarum. Int J Eat Disord 1999; 26:223-7.
168. Glencross PM, Ledingham DD, Alexander JA. Acute porphyria presenting with hyperamylasemia. Dig Dis Sci 1991; 36:370-2.
169. Pierach CA, Bossenmaier IC, Weimer MK. Acute porphyria with hyperamylasemia. Dig Dis Sci 1991; 36:1803.
170. Kurosawa M, Terashima K, Nishimaki T, Morito T, Kasukawa R. Hyperamylasemia in systemic lupus erythematosus (SLE). Ryumachi 1988; 28:14-9.
171. Goto H, Wakui H, Komatsuda A, Imai H, Miura AB, Fujita K. Simultaneous macroamylasemia and macrolipasemia in a patient with systemic lupus erythematosus in remission. Intern Med 2000; 39:1115-8.
172. Tsianos EB, Tzioufas AG, Kita MD, Tsolas O, Moutsopoulos HM. Serum isoamylases in patients with autoimmune rheumatic diseases. Clin Exp Rheumatol 1984; 2:235-8.
173. MacGregor IL, Zakim D. A cause of hyperamylasemia associated with chronic liver disease. Gastroenterology 1977; 72:519-23.
174. Skrha J, Stepan J, Hazuka V, Pacovsky V. Serum isoamylases in acute and chronic liver disease. Z Gastroenterol 1984; 22:255-8.
175. Piteira Barros F, Espinheira R, Geada H, de Moura MC. Hyperamylasemia with an abnormal isoamylase distribution in patients with liver diseases. Am J Gastroenterol 1986; 81:261-5.
176. Hatta Y, Yoshikawa N, Funatomi H, Taguchi S. Hyperamylasemia and S-type isozyme dominance in liver cirrhosis. Int J Pancreatol 1987; 2:371-81.
177. Sugimoto K, Shiraki K, Yamanaka T, Okano H, Deguchi M, Omori S, et al. Hyperamylasemia associated with hepatocellular carcinoma. J Clin Gastroenterol 2001; 32:463-4.
178. Chosidow O, el Wady Z, Devanlay M, Jaffray P, Revuz J, Roujeau JC. Hyperamylasemia in toxic epidermal necrolysis. Arch Dermatol 1993; 129:792-3.
179. Edwards CN, Evarard CO. Hyperamylasemia and pancreatitis in leptospirosis: Am J Gastroenterol 1991; 86:1665-8.
180. Pai ND, Adhikari P. Painless pancreatitis: a rare manifestation of leptospirosis. J Assoc Physicians India 2002; 50:1318-9.
181. Daher Ede F, Brunetta DM, de Silva Junior GB, Puster RA, Patrocinio RM. Pancreatic involvement in fatal human leptospirosis: clinical and histopathological features. Rev Inst Med Trop Sao Paulo 2003; 45:307-13.
182. Lin XZ, Chen TW, Wang SS, Shiesh SC, Tsai YT, Huang TP, et al. Pancreatic enzymes in uremic patients with or without dialysis. Clin Biochem 1988; 21:189-92.
183. Tsianos EV, Dardamanis MA, Elisaf M, Vasakos S, Siamopoulos KC. The value of alpha-amylase and isoamylase determination in chronic renal failure patients. Int J Pancreatol 1994; 15:105-11.
184. Dardamanis MA, Elisaf MS, Vasakos SA, Tsianos EV, Siamopoulos KC. alpha-Amylase and isoamylase levels in renal transplant recipients compared to uremic patients. Ren Fail 1995; 17:715-9.
185. Duerksen DR, Tsang M, Parry DM. Chronic hyperlipasemia caused by sarcoidosis. Dig Dis Sci 2000; 45:1545-8.
186. Munk Z, Tolis G, Jones W, Fallen E, McLean P. Pheochromocytoma presenting with pulmonary edema and hyperamylasemia. Can Med Assoc J 1977; 116:357-9.
187. Kim SY, Kim JH, Kim CH, Nam SW, Kim YJ, Kim JI, et al. A case of pheochromocytoma with hyperamylasemia. Korean J Gastroenterol 2003; 42:172-5.
188. Matsuzaki H, Hata H, Takeya M, Takatsuki K. Establishment and characterization of an amylase-producing human myeloma cell line. Blood 1988; 72:978-82.
189. Lopez J, Ulibarrena C, Gonzalez-Porque P, Navas G, Roldan E, Cancelas JA, et al. Amylase-producing Bence Jones multiple myeloma with pancreatitis-like symptoms. Acta Haematol 1993; 90:99-101.
190. Ross CM, Devgun MS, Gunn IR. Hyperamylasaemia and multiple myeloma. Ann Clin Biochem 2002; 39:616-20.
191. Tsai YS, Cheng HL, Lin JS, Tong YC, Chang KC. Retroperitoneal plasmacytoma associated with hyperamylasemia. J Urol 1999; 162:1681-2.
192. Stein L, Bank S, Rai K. Hyperamylasemia and hematologic malignancies. Ann Intern Med 1992; 116:266-7.
193. Weitzel JN, Pooler PA, Mohammed R, Levitt MD, Eckfeldt JH. A unique case of breast carcinoma producing pancreatic-type isoamylase. Gastroenterology 1988; 94:519-20.
194. Katayama S, Ikeuchi M, Kanazawa Y, Akanuma Y, Kosaka K, Takeuchi T, Nakayama T. Amylase-producing lung cancer: case report and review of the literature. Cancer 1981; 48:2499-502.
195. Maeda M, Otsuki M, Yuu H, Saeki S, Yamasaki T, Baba S. Salivary-type hyperamylasemia in primary lung cancer: observation of a possible precursor of the salivary-type isoamylase. Eur J Cancer Clin Oncol 1982; 18:123-8.
196. Schmidt LE, Dalhoff K. Hyperamylasaemia and acute pancreatitis in paracetamol poisoning. Aliment Pharmacol Ther 2004; 20:173-9.
197. Takagi H, Yasue M, Morimoto T, Kuroyanagi Y, Imanaga H. Asymptomatic transient hyperamylasemia after a large intravenous dose of steroid hormone. Am J Surg 1977; 133:322-5.
198. Toubanakis C, Batziou E, Sipsas N, Galanopoulos G, Tzivras M, Archimandritis A. Acute pancreatitis after long-term therapy with mesalazine, and hyperamylasaemia associated with azathioprine in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 2003; 15:933-4.
199. Takahashi T, Minakami H, Tamada T, Sato I. Hyperamylasemia in response to ritodrine or ephedrine administered to pregnant women. J Am Coll Surg 1997; 184:31-6.
200. Baniel J, Leibovitch I, Foster RS, Rowland RG, Bihrle R, Donohue JP. Hyperamylasemia after post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 1995; 154:1373-5.
201. de la Fuente Aguado J, Prieto Lopez MI, Bordon JM, Rivera Gallego A, Sopena Perez-Arguelles B. Hyperamylasemia associated with roxithromycin. An Med Interna 1993; 10:260.
202. Prevost X, Myara I, Cosson C, Duboust A, Moatti N. Asymptomatic hyperamylasemia after cyclosporine therapy in patients with renal transplants. Transplant Proc 1988; 20:555-8.
203. Bergemann N, Ehrig C, Diebold K, Mundt C, von Einsiedel R. Asymptomatic pancreatitis associated with clozapine. Pharmacopsychiatry 1999; 32:78-80.
204. O'Brien JG, Dong BJ, Coleman RL, Gee L, Balano KB. A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia. Clin Infect Dis 1997; 24:854-9.
205. Nelson MR, Moyle GJ, Gazzard BG. Use of didanosine in zidovudine-intolerant patients infected with human immunodeficiency virus. Clin Infect Dis 1993; 16 Suppl 1:S59-62.
206. Morrissey R, Berk JE, Fridhandler L, Pelot D. The nature and significance of hyperamylasemia follwing operation. Ann Surg 1974; 180:67-71.
207. Korenaga D, Watanabe A, Baba H, Saito A, Maehara Y, Sugimachi K. Hyperamylasemia associated with lymphadenectomy in patients surgically treated for gastric cancer. Eur J Surg Oncol 1992; 18:135-41.
208. Tsuzuki T, Shimizu S, Takahashi S, Iio H. Hyperamylasemia after hepatic resection. Am J Gastroenterol 1993; 88:734-6.
209. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Changes in serum amylase level following hepatic resection in chronic liver disease. Arch Surg 1994; 129:634-8.
210. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T, Hayashi K, Kasai H. Serum Amylase elevation following hepatic resection in patients with chronic liver disease. Am J Surg 1996; 171:235-8.
211. Hotta T, Kobayashi Y, Taniguchi K, Johata K, Sahara M, Watanabe T, Tanimura H. Hyperamylasemia after hepatectomy in chronic liver disease patients. Hepatogastroenterology 2003; 50:1060-5.
212. Haas GE, Segal LB. Hyperamylasemia and pancreatitis following biliary tract surgery: a prospective study. J Am Osteopath Assoc 1985; 85:519-27.
213. Otsuki M, Maeda M, Yuu H, Yamasaki T, Okano K. The nature and origin of hyperamylasemia following open-heart surgery with extracorporeal circulation. Clin Chim Acta 1977; 77:349-57.
214. Missavage AE, Weaver DW, Bouwman DL, Parnell V, Wilson RF. Hyperamylasemia after cardiopulmonary bypass. Am Surg 1984; 50:297-300.
215. Haas GS, Warshaw AL, Daggett WM, Aretz HT. Acute pancreatitis after cardiopulmonary bypass. Am J Surg 1985; 149:508-15.
216. Svensson LG, Decker G, Kinsley RB. A prospective study of hyperamylasemia and pancreatitis after cardiopulmonary bypass. Ann Thorac Surg 1985; 39:409-11.
217. Kazmierczak SC, Van Lente F. Incidence and source of hyperamylasemia after cardiac surgery. Clin Chem 1988; 34:916-9.
218. Rattner DW, Gu ZY, Vlahakes GJ, Warshaw AL. Hyperamylasemia after cardiac surgery. Incidence, significance, and management. Ann Surg 1989; 209:279-83.
219. Fernandez-del Castillo C, Harringer W, Warshaw AL, Vlahakes GJ, Koski G, Zaslavsky AM, Rattner DW. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991; 325:382-7.
220. Chang H, Chung YT, Wu GJ, Hwang FY, Chen KT, Peng WL, Hung CR. Hyperamylasemia following cardiopulmonary bypass. J Formos Med Assoc 1992; 91:34-40.
221. Babineau TJ, Hernandez E, Forse RA, Bistrian BR. Symptomatic hyperlipasemia after cardiopulmonary bypass: implications for enteral nutritional support. Nutrition 1993; 9:237-9.
222. Paajanen H, Harmoinen A, Sisto T, Tarkka M, Metsa-Ketela T, Iovanna JL, et al. Effect of antioxidants on postoperative hyperamylasemia in coronary bypass surgery. Pancreas 1996; 13:236-40.
223. Tikanoja T, Rautiainen P, Leijala M, Svens E, Tikanoja S. Hyperamylasemia after cardiac surgery in infants and children. Intensive Care Med 1996; 22:959-63.
224. Ihaya A, Muraoka R, Chiba Y, Kimura T, Uesaka T, Morioka K, et al. Hyperamylasemia and subclinical pancreatitis after cardiac surgery. World J Surg 2001; 25:862-4.
225. Hashimoto L, Walsh RM. Acute pancreatitis after aortic surgery. Am Surg 1999; 65:423-6.
226. Alexander JA, Demetrius AJ, Gavaler JS, Makowka L, Starzl TE, Van Thiel DH. Pancreatitis following liver transplantation. Transplantation 1988; 45:1062-5.
227. Christoforidis E, Goulimaris I, Kanellos I, Tsalis K, Demetriades C, Betsis D. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors. Endoscopy 2002; 34:286-92.
228. Testoni PA, Bagnolo P, Caporuscio S, Lella F. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis. Am J Gastroenterol 1999; 94:1235-41.